Global Dialysis

Dialysis industry news

Stories from the dialysis comunity across the globe.

Randomized trial of hemodiafiltration vs. low-flux dialysis shows no overall benefit.

JASN: In conclusion, this trial did not detect a beneficial effect of hemodiafiltration on all-cause mortality and cardiovascular events compared with low-flux hemodialysis. On-treatment analysis suggests the possibility of a survival benefit among patients who receive high-volume hemodiafiltration, although this subgroup finding requires confirmation.

...

FDA approves everolimus for treatment of kidney angiomyolipomas associated with tuberous sclerosis.

FDA: The U.S. Food and Drug Administration today approved Afinitor (everolimus), the first drug approved specifically to treat non-cancerous kidney tumors (renal angiomyolipomas) not requiring immediate surgery in patients with tuberous sclerosis complex (TSC).

...

Facebook sets up a mechanism for its users to declare their organ donor status.

CNN: The Facebook tool works like this: Users go to their timelines, where under Life Event they will see a health and wellness section. Zuckerberg said: "You put in, 'I decided to be an organ donor' and your state or country you live in and you can add a story about how you decided to be an organ donor." A Facebook user will also see a Share Your Donor Status link when a friend's donor update hits their news feed.

...

Renal denervation devicemakers in the news: Covidien and Maya medical.

Med City News: A Covidien spokesman wouldn’t comment what he described as “market rumors and speculation” but conceded that the company is in “partnership with Maya on a new technology.” The spokesman, Bruce Farmer, went on to add that Covidien makes strategic investments from time to time and “is a recognized market leader in RF ablation technology, with numerous products in both its Vascular and Surgical portfolios…”

...

Nephros gets 510k approval from FDA for it's add-on hemodiafiltration module.

Sacramento Bee: Nephros, Inc. (OTC Bulletin Board: NEPH), a medical device company developing and marketing filtration products for therapeutic applications and advanced water purification solutions, today announced the Company has received 510(k) clearance from the Food and Drug Administration ("FDA") to market its Hemodiafiltration ("HDF") system for the treatment of chronic renal failure when used with UF controlled dialysis machines capable of producing ultrapure dialysate in accordance with current AAMI/ANSI/ISO standards in the United States.

...

More Articles...

<< Start < Prev 741 742 743 744 745 746 747 748 749 750 Next > End >>

Page 744 of 4210

Share |

Empowering dialysis users and caregivers

Search for dialysis centres here

Jobs in dialysis

Dialysis travel

Dialysis information

Translate Global Dialysis

Dialysis centre search LOGIN HERE

Resources